Autosomal Recessive Polycystic Kidney DiseaseSymptoms, Doctors, Treatments, Advances & More
Autosomal Recessive Polycystic Kidney Disease Overview
Learn About Autosomal Recessive Polycystic Kidney Disease
- Autosomal recessive polycystic kidney disease
- ARPKD
- Polycystic kidney disease, infantile type
Cleveland Clinic Children's Outpatient Center
Katherine Dell is a Pediatric Nephrologist practicing medicine in Cleveland, Ohio. She has been practicing medicine for over 39 years. Dr. Dell is rated as an Elite provider by MediFind in the treatment of Autosomal Recessive Polycystic Kidney Disease. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Autosomal Recessive Polycystic Kidney Disease, Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, and Minimal Change Disease. Dr. Dell is board certified in American Board Of Pediatrics, 1999.
Office
Erum Hartung is a Pediatric Nephrologist practicing medicine in Philadelphia, Pennsylvania. Dr. Hartung is rated as an Elite provider by MediFind in the treatment of Autosomal Recessive Polycystic Kidney Disease. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Autosomal Recessive Polycystic Kidney Disease, Polycystic Kidney Disease, Potter Syndrome, Autosomal Dominant Polycystic Kidney Disease, and Kidney Transplant.
Max Liebau practices practicing medicine in Koeln, Germany. Mr. Liebau is rated as an Elite expert by MediFind in the treatment of Autosomal Recessive Polycystic Kidney Disease. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Autosomal Recessive Polycystic Kidney Disease, Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, Kidney Transplant, and Nephrectomy.
Summary: Cell-free fetal DNA (cffDNA) is present in the maternal blood from the early first trimester of gestation and makes up 5%-20% of the total circulating cell-free DNA (cfDNA) in maternal plasma. Its presence in maternal plasma has allowed development of noninvasive prenatal diagnosis for single-gene disorders (SGD-NIPD). This can be performed from 9 weeks of amenorrhea and offers an early, safe and ...
Summary: Autosomal Recessive Polycystic Kidney Disease (ARPKD) is a potentially lethal genetic disorder for which there are currently no disease specific treatments. Clinical trials have been limited by the absence of robust measures of disease progression. The overall goal of this 5 year NIH-funded prospective, observational multicenter study conducted at CC (primary site) and Children's Hospital of Phila...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center
